Empowering specificity of AML immunotherapies by HSC engineering |
Aflac Cancer Center and Blood Disorders Service of Children’s Healthcare of Atlanta / Pietro Genovese |
Catalyst Grants |
2023 |
Georgia |
Mutagenesis and disease progression in RUNX1 mutant blood stem cells is caused by inflammation-induced hyperactive signaling and supraphysiological mitochondrial ROS |
St. Jude Children’s Research Hospital / Dirk Loeffler, PhD |
RUNX1 Early Career Investigator Grants |
2023 |
Tennessee |
Immunoglobulin High-Throughput Sequencing for Refining Risk Stratification in Infant B-ALL |
University of Rochester / Carol Fries Simpson, MD |
Reach Grants |
2023 |
New York |
Identification of Aberrantly Methylated Differentially Expressed Genes to Distinguish High- vs. Low-Risk Retinoblastoma |
Children’s Hospital Los Angeles / Jesse Berry, MD |
Reach Grants |
2023 |
California |
Mechanisms to Redirect Tumor Associated Macrophages to Target Retinoblastoma Cells |
The Regents of the University of Minnesota / Timothy Hallstrom, PhD |
Innovation Grants |
2023 |
Minnesota |
Targeting Chromatin Remodeling Complexes for Rhabdomyosarcoma (RMS) Therapy |
Dana-Farber Cancer Institute / Jun Qi, PhD |
Innovation Grants |
2023 |
Massachusetts |
Targeting Neurons in the Osteosarcoma Microenvironment with Non-Opioid Analgesic Lipid Nanoparticles |
The Johns Hopkins University School of Medicine / Aaron James, MD, PhD |
Innovation Grants |
2023 |
Maryland |
Structure-guided de novo design of molecules that selectively target EWS-FLI1 |
University of Texas Health Science Center at San Antonio / David Libich, PhD |
Innovation Grants |
2023 |
Texas |
Targeting the Checkpoint Receptor TIGIT via CRISPR/Cas9 Genome Editing to Enhance NK Cell Anti-Tumor Activity |
Research Institute at Nationwide Children's Hospital / Amanda Campbell, MD/PhD |
Young Investigator Grants |
2023 |
Ohio |
Mechanisms of BRAF Activation in KIAA1549-BRAF Mutant pLGGs |
Broad Institute / Sean Misek, PhD |
Young Investigator Grants |
2023 |
Massachusetts |